|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| A61K 31/535 | |||
| A61K 31/65 | |||
| A61K 31/435 | |||
| A61K 31/505 | |||
| A61K 31/47 |
| (11) | Number of the document | 1769795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06023696.5 |
| Date of filing the European patent application | 2002-12-03 | |
| (97) | Date of publication of the European application | 2007-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 334609 P | 2001-12-03 | US |
| (72) |
Carter, Christopher A., US
Gibson, Neil, US
Hibner, Barbara, US
Humphrey, Rachel W., US
Trail, Pamela, US
Vincent, Patrick W., US
Zhai, Yifan, US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (54) | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |